Flat Tummy Tea Brand And Claim Roundly Rejected In UK
This article was originally published in The Rose Sheet
Nomad Choice surprised by UK use of EU Register list of authorized health claims and by ASA's finding that "flat" in the brand name also is an unauthorized claim.
You may also be interested in...
NAD advises Fit Products to modify FitTea claims because its formulation is not the same as studies submitted and reminds the firm that testimonials must not contain false claims about products.
The amyloid-targeting drug is years behind Biogen/Eisai’s aducanumab, but its subcutaneous administration and the GRADUATE studies’ design could give Roche’s gantenerumab an advantage.
Correvio's atrial fibrillation drug Brinavess will return to a US FDA advisory committee more than a decade after the agency first declined to approve the drug; FDA still has a series of cardiovascular safety concerns related to the drug and is not convinced by data from the European experience.